The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer
Open accessPublished version of a preprint
Abstract
Pancreatic cancer is the most lethal common solid malignancy. Systemic therapies are often ineffective, and predictive biomarkers to guide treatment are urgently needed. We generated a pancreatic cancer patient–derived organoid (PDO) library that recapitulates the mutational spectrum and transcriptional subtypes of primary pancreatic cancer. New driver oncogenes were nominated and transcriptomic analyses revealed unique clusters. PDOs exhibited heterogeneous responses to standard-of-care chemotherapeutics and investigational agents. In a case study manner, we found that PDO therapeutic profiles paralleled patient outcomes and that PDOs enabled longitudinal assessment of chemosensitivity and evaluation of synchronous metastases. We derived organoid-based gene expression signatures of chemosensitivity that predicted improved responses for many patients to chemotherapy in both the adjuvant and advanced disease settings. Finally, we nominated alternative treatment strategies for chemorefractory PDOs using targeted agent therapeutic profiling. We propose that combined molecular and therapeutic profiling of PDOs may predict clinical response and enable prospective therapeutic selection. Significance: New approaches to prioritize treatment strategies are urgently needed to improve survival and quality of life for patients with pancreatic cancer. Combined genomic, transcriptomic, and therapeutic profiling of PDOs can identify molecular and functional subtypes of pancreatic cancer, predict therapeutic responses, and facilitate precision medicine for patients with pancreatic cancer. Cancer Discov; 8(9); 1112–29. ©2018 AACR. See related commentary by Collisson, p. 1062. This article is highlighted in the In This Issue feature, p. 1047
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“114 PDO cultures from 101 patients were generated127 and subjected to transcriptomic profiling, followed by therapeutic profiling”
From Human disease models in drug development (2023) · cites this paper as [127]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recently, normal and tumor organoid models have been developed from both human and mouse pancreas (82, 83).”
From KRAS mutation in pancreatic cancer (2021) · cites this paper as [83]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The treatment outcome of the PDOs positively correlated with individual patient responses”
From Human disease models in drug development (2023) · cites this paper as [127]
The cited source says what the claim attributes to it.
In the citing paper
“patient-derived tumoroid models also show promise in testing drug efficacy and potentially determining a personalized treatment for the patient7–12.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [10]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This heterogeneity in treatment responses is now being exploited for the treatment of cystic fibrosis patients191, with a large ongoing European multicentre clinical trial study, led by the HIT-Cystic Fibrosis consortium, to identify potential responders214.”
From Organoids (2022) · cites this paper as [214]
Experimental — accuracy not yet measured
In the citing paper
“Furthermore, with recent technological advancements (e.g. organoid models and conditionally reprogrammed cell lines), a new generation of cancer cell models is being derived to allow full representation of the histopathological and molecular diversity of tumours (37–42).”
From Cell Model Passports-a hub for clinical, genetic and functional datasets of preclinical cancer models (2019) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2000) · doi:10.32614/r.manuals · Cited by 355,893
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
Complex heatmaps reveal patterns and correlations in multidimensional genomic data
Gu, Z., Eils, R., & Schlesner, M. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw313 · Cited by 10,037
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Conroy, T., Desseigne, F., Ychou, M., Bouché, O., Guimbaud, R., Bécouarn, Y., Adenis, A., Raoul, J.-L., Gourgou-Bourgade, S., de la Fouchardière, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011923 · Cited by 7,810
Cited by
Sorted by citations
Items 601–700 of 1,001
Zhang, H., Wu, J., Yuan, J., Li, H., Zhang, Y., Wang, W., Chen, W., Wang, C., Meng, S., Chen, S., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02052-z · Cited by 10
RetractedRaghavan, S., Winter, P. S., Navia, A. W., Williams, H. L., DenAdel, A., Kalekar, R. L., Galvez-Reyes, J., Lowder, K. E., Mulugeta, N., Raghavan, M. S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.25.256214 · Cited by 10
Self-citationMolecular Pathology of Pancreatic Cancer
Karamitopoulou, E. (2022) · Cancers · doi:10.3390/cancers14061523 · Cited by 10
LeSavage, B. L., Gilchrist, A. E., Krajina, B. A., Karlsson, K., Smith, A. R., Karagyozova, K., Klett, K. C., Curtis, C. N., Kuo, C. J., & Heilshorn, S. C. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.22.488943 · Cited by 10
Next-Generation Modeling of Cancer Using OrganoidsPreprint
Love, J. R., & Karthaus, W. R. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041380 · Cited by 9
Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinomaPreprint
Wasko, U. N., Jiang, J., Curiel‐García, Á., Wang, Y., Lee, B. J., Orlen, M., Drizyte‐Miller, K., Menard, M. J., Dilly, J., Sastra, S. A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.03.569791 · Cited by 10
Self-citationTotal Neoadjuvant Therapy in Localized Pancreatic Cancer: Is More Better?
Saúde-Conde, R., Ghali, B. E., Navez, J., Bouchart, C., & Laethem, J. V. (2024) · Cancers · doi:10.3390/cancers16132423 · Cited by 9
Liang, J., Zhao, D., Yin, H.-M., Tian, T.-Y., Kang, J.-K., Shen, S., & Wang, J. (2025) · Nano Today · doi:10.1016/j.nantod.2025.102665 · Cited by 10
Chen, Y., Zhang, J., Zhang, B., Lee, H. K., Xie, S., Shen, W., Chen, X., You, M., Shen, C., Xia, B., et al. (2025) · Biology Methods and Protocols · doi:10.1093/biomethods/bpaf012 · Cited by 9
Dejun, Y., Zhang, X., Hu, Z., Sun, Q., Fu, H., Yao, J., Zheng, B., Zhang, X., & Wang, W. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217617 · Cited by 9
Nitschke, C., Phan, C., Souto, Y., Walter, P., Goetz, M. R., Simkus, G., Thastrup, J., Simon, R., Kupper, J., Izbicki, J. R., et al. (2025) · International Journal of Cancer · doi:10.1002/ijc.35443 · Cited by 9
Mimicking breast cancer tissue—3D bioprinted models in accurate drug sensitivity tests
Petővári, G., Moldvai, D., Raffay, R. E., Dankó, T., Sztankovics, D., Reszegi, A., Miyaura, R., Gelencsér, R., Rókusz, A., Tolnai‐Kriston, C., et al. (2025) · Open Research (University of Surrey) · doi:10.1002/viw.20250092 · Cited by 9
ZBTB11 depletion targets metabolic vulnerabilities in KRAS inhibitor-resistant PDAC
Tran, N. L., Jiang, J., Ma, M., Gadbois, G. E., Gulay, K. C. M., Verano, A. L., Schiavon, C. R., Rebollo, E., Zhou, H., Huang, C., et al. (2025) · Nature Chemical Biology · doi:10.1038/s41589-025-01978-1 · Cited by 14
Self-citationLiu, Y., Zhang, Y., Zhang, R., Zhang, C., & Liu, X. (2025) · Cancer Biology & Therapy · doi:10.1080/15384047.2025.2567802 · Cited by 11
Pancreatic Cancer Organoids: Modeling Disease and Guiding Therapy
Morceau, F., El‐Khoury, V., Lee, K., Berna, M. J., & Kwon, Y. (2025) · Cancers · doi:10.3390/cancers17233850 · Cited by 10
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Rabago, D. B., Blakely, C. M., Haderk, F., & Bivona, T. G. (2021) · Journal of Visualized Experiments · doi:10.3791/63039 · Cited by 11
Gong, M., Meng, H., Tan, D., Li, P., Qin, J., An, Q., Shi, C., & An, J. (2023) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12352 · Cited by 9
Obreque, J., Vergara-Gómez, L., Venegas, N., Weber, H. L., Owen, G. I., Pérez, P. E., Leal, P., Roa, J. C., & Bizama, C. (2023) · Biological Research · doi:10.1186/s40659-023-00476-9 · Cited by 11
Steiner, S., Pliego‐Mendieta, A., Haberecker, M., Hussung, S., Kollár, A., Fritsch, R., Arnold, F. M., Lenggenhager, D. M., Planas‐Paz, L., & Pauli, C. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216650 · Cited by 10
Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC
Musiu, C., Lupo, F., Agostini, A., Lionetto, G., Bevere, M., Paiella, S., Carbone, C., Corbo, V., Ugel, S., & Sanctis, F. D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1341079 · Cited by 9
Advancing precision medicine in esophageal squamous cell carcinoma using patient-derived organoids
Shen, S., Liu, B., Guan, W., Liu, Z., Han, Y., Hu, Y., Chen, Y., Liu, S., He, J., Li, Z., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05967-1 · Cited by 10
Thomas, A., do Canto, L. M., Rainho, C. A., Juengel, E., Blaheta, R. A., Spiess, P. E., Rogatto, S. R., & Tsaur, I. (2021) · Translational Andrology and Urology · doi:10.21037/tau-20-945 · Cited by 9
Endoscopic Ultrasound-Guided Sampling for Personalized Pancreatic Cancer Treatment
Iwasaki, E., Fukuhara, S., Horibe, M., Kawasaki, S., Seino, T., Takimoto, Y., Tamagawa, H., Machida, Y., Kayashima, A., Noda, M., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11030469 · Cited by 9
Combined Systemic Drug Treatment with Proton Therapy: Investigations on Patient-Derived Organoids
Naumann, M., Czempiel, T., Lößner, A. J., Pape, K., Beyreuther, E., Löck, S., Drukewitz, S., Hennig, A., von Neubeck, C., Klink, B., et al. (2022) · Cancers · doi:10.3390/cancers14153781 · Cited by 9
Prasse, P., Iversen, P., Lienhard, M., Thedinga, K., Herwig, R., & Scheffer, T. (2022) · Cancers · doi:10.3390/cancers14163950 · Cited by 9
JNK inhibitor IX restrains pancreatic cancer through p53 and p21
Shi, J., Yang, X., Kang, Q., Lu, J., Denzinger, M., Kornmann, M., & Traub, B. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1006131 · Cited by 9
Kim, S., Woo, K. J., Yang, C.-M., Park, S. H., Hwang, J. C., Yoo, B. M., Kim, J. H., Lee, D., & Yang, M. J. (2023) · Digestive Endoscopy · doi:10.1111/den.14648 · Cited by 9
Self-citationTalwelkar, S. S., Nagaraj, A. S., Devlin, J. R., Hemmes, A., Potdar, S., Kiss, E. A., Saharinen, P., Salmenkivi, K., Mäyränpää, M. I., Wennerberg, K., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0573 · Cited by 7
Predicting Gemcitabine Delivery by18F-FAC PET in Murine Models of Pancreatic Cancer
Russell, J., Grkovski, M., O’Donoghue, I., Kalidindi, T. M., Pillarsetty, N., Burnazi, E. M., Kulick, A. R., Bahr, A., Chang, Q., Lekaye, C., et al. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.246926 · Cited by 9
Self-citationThree Dimensional Models of Endocrine Organs and Target Tissues Regulated by the Endocrine System
Luca, E., Zitzmann, K., Bornstein, S. R., Kugelmeier, P., Beuschlein, F., Nölting, S., & Hantel, C. (2023) · Cancers · doi:10.3390/cancers15184601 · Cited by 10
Wittenzellner, K., Lengl, M., Röhrl, S., Maurer, H. C., Klenk, C., Papargyriou, A., Schmidleitner, L., Kabella, N., Shastri, A., Fresacher, D., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.169105 · Cited by 9
Sullivan, R. J., Cillo, A. R., Ferris, R. L., Jenkins, R. W., Kluger, H. M., Kok, M., Lipson, E. J., Paruzzo, L., Redmond, W. L., Ruella, M., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-011929 · Cited by 11
Deciphering Breast Tumor Heterogeneity Through Patient-Derived Organoids and Circulating Tumor Cells
Policastro, B., Nissen, N., & Alves, C. L. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15070271 · Cited by 8
Liu, J., Fang, F., Yuan, W., Chen, T., Ji, W., Miao, X., Meng, Y., Chen, S., Tan, W., An, J., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-25-0608 · Cited by 8
Hendriks, H. R. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189467 · Cited by 11
State-matched organoid models to fight pancreatic cancer
Melzer, M. K., Roger, É., & Kleger, A. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.03.003 · Cited by 8
Koga, T., Soh, J., Hamada, A., Miyano, Y., Fujino, T., Obata, K., Ohara, S., Nishino, M., Chiba, M., Shimoji, M., et al. (2023) · JTO Clinical and Research Reports · doi:10.1016/j.jtocrr.2023.100554 · Cited by 8
Engrailed‐1 Promotes Pancreatic Cancer Metastasis
Xu, J., Roe, J., Lee, E., Tonelli, C., Ji, K. Y., Younis, O. W., Somervile, T. D. D., Yao, M. A., Milazzo, J. P., Tiriac, H., et al. (2023) · Advanced Science · doi:10.1002/advs.202308537 · Cited by 10
Self-citationPrimary liver cancer organoids and their application to research and therapy
Zhu, X., Trehan, R., & Xie, C. (2024) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2024.06.002 · Cited by 8
Evolving Treatment Paradigms for Pancreatic Cancer
Abbassi, R., & Schmid, R. M. (2019) · Visceral Medicine · doi:10.1159/000503797 · Cited by 8
Lee, H. S., Kim, E., Lee, J., Park, S. J., Hwang, H. K., Park, C. H., Jo, S.-Y., Kang, C. M., Hong, S., Kang, H., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103218 · Cited by 8
Self-citationKutschat, A. P., Johnsen, S. A., & Hamdan, F. H. (2021) · Cells · doi:10.3390/cells10050966 · Cited by 9
Advances in preclinical evaluation of experimental antibody-drug conjugates
Lyons, S. K., Plenker, D., & Trotman, L. C. (2021) · Cancer Drug Resistance · doi:10.20517/cdr.2021.37 · Cited by 8
Self-citationLundy, J., Harris, M., Zalcberg, J. R., Zimet, A. S., Goldstein, D., Gebski, V., Borsaru, A., Desmond, C., Swan, M. P., Jenkins, B. J., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.770022 · Cited by 8
Chen, L., Tian, B., Liu, W., Liang, H., You, Y., & Liu, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.855674 · Cited by 9
Emerging Role for 7T MRI and Metabolic Imaging for Pancreatic and Liver Cancer
Rivera, D. S. (2022) · Metabolites · doi:10.3390/metabo12050409 · Cited by 8
Zhang, W., Zhan, J., Zhao, R., Xu, Y., Zeng, Y., Xiao, Q., Ye, W., Wu, Y., Cai, Y., & Fang, C. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202203767 · Cited by 7
3D Culture of Primary Patient-Derived Hepatoblastoma Tumoroids
Wu, P. V., & Nusse, R. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2557-6_19 · Cited by 7
Organoids for Modeling (Colorectal) Cancer in a Dish
Rathje, F., Klingler, S., & Aberger, F. (2022) · Cancers · doi:10.3390/cancers14215416 · Cited by 10
Gassl, V., Aberle, M. R., Boonen, B., Vaes, R. D. W., Damink, S. W. M. O., & Rensen, S. S. (2022) · Cancers · doi:10.3390/cancers14225617 · Cited by 9
Has Personalized Medicine for Pancreatic Cancer Arrived?
Krepline, A. N., & Tsai, S. (2019) · Advances in Surgery · doi:10.1016/j.yasu.2019.04.006 · Cited by 8
Bispo, M., Marques, S., Rio‐Tinto, R., Fidalgo, P. O., & Deviere, J. M. E. (2020) · GE Portuguese Journal of Gastroenterology · doi:10.1159/000509197 · Cited by 8
Kawalerski, R. R., Leach, S. D., & Escobar‐Hoyos, L. F. (2021) · Oncotarget · doi:10.18632/oncotarget.27901 · Cited by 8
Immunofluorescence staining of colorectal cancer patient-derived organoids
Regan, J. L. (2022) · Methods in cell biology · doi:10.1016/bs.mcb.2022.04.008 · Cited by 8
Refining Classification of Pancreatic Cancer Subtypes to Improve Clinical Care
Aguirre, A. J. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.11.004 · Cited by 8
Self-citationPatient-Derived Sarcoma Organoids Offer a Novel Platform for Personalized Precision Medicine
Sánchez‐Fdez, A., Sharma, A. K., Tiriac, H., & Sicklick, J. K. (2022) · Annals of Surgical Oncology · doi:10.1245/s10434-022-12152-5 · Cited by 8
Self-citationSkubleny, D., Garg, S., Wickware, J., Purich, K., Ghosh, S., Spratlin, J. L., Schiller, D., & Rayat, G. R. (2023) · Biomedicines · doi:10.3390/biomedicines11010151 · Cited by 7
Ren, J., Liu, M., Rong, M., Zhang, X., Wang, G., Liu, Y., Li, H., & Duan, S. (2024) · Cell organoid (Print) · doi:10.26599/co.2024.9410009 · Cited by 8
Lum, M. A., Jonas, K. A., Parmar, S., Black, A. R., O’Connor, C. M., Dobersch, S., Yamamoto, N., Robertson, T. M., Schutter, A., Giambi, M., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci176093 · Cited by 7
Schwerd‐Kleine, P., Würth, R., Cheytan, T., Michel, L. L., Thewes, V., Gutjahr, E., Seker‐Cin, H., Kazdal, D. N., Neuberth, S., Thiel, V., et al. (2025) · International Journal of Cancer · doi:10.1002/ijc.35386 · Cited by 7
Developments in gastrointestinal organoid cultures to recapitulate tissue environments
Kuhn, M. R., Wolcott, E. A., & Langer, E. M. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1521044 · Cited by 10
Multi-drug pharmacotyping improves therapy prediction in pancreatic cancer organoids
Wansch, K., Pelzer, U., Schneider, F., Dölvers, F., Kühn, A., Dragomir, M. P., Ihlow, J., Hilfenhaus, G., Vecchione, L., Felsenstein, M., et al. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03969-7 · Cited by 7
Nikeghbal, P., Zamanian, D., Burke, D., & Steinkamp, M. P. (2025) · BMC Cancer · doi:10.1186/s12885-025-14811-8 · Cited by 9
Patient-Derived Tumour Organoids (PDOs) may help oncologists in clinical practice
Brandi, R., Palcau, A. C., Migliano, E., Strano, S., & Blandino, G. (2025) · Personalized Medicine · doi:10.1080/17410541.2025.2581557 · Cited by 7
AI-Enhanced Patient-Derived Cancer Organoids: Integrating Machine Learning for Precision Oncology
Heinzelmann, E., & Piraino, F. (2025) · Organoids · doi:10.3390/organoids4040030 · Cited by 7
Jiang, S., Song, Y., Peng, Y., Yan, R., Niu, Y., Chen, B., Lin, J., Wu, J., Wang, S., Du, Y., et al. (2026) · iMeta · doi:10.1002/imt2.70130 · Cited by 9
A compendium of next-generation patient-derived models for diverse cancers
ElHarouni, D., Al‐Jazrawe, M., Choi, S., Dede, M., Hinoue, T., Misek, S. A., Noh, H., Zanella, L., Tseng, Y.-Y., Francies, H. E., et al. (2026) · Nature · doi:10.1038/s41586-026-10806-y · Cited by 9
Self-citationGeneration of Human Kidney Tubuloids from Tissue and Urine
Calandrini, C., & Drost, J. (2021) · Journal of Visualized Experiments · doi:10.3791/62404 · Cited by 8
Özer, M., Ranganathan, M., Lecomte, N., Schvartzman, J. M., Walch, H. S., Chatila, W. K., Hong, J., Carlo, M. I., Walsh, M. F., Sheehan, M. R., et al. (2022) · JCO Precision Oncology · doi:10.1200/po.21.00560 · Cited by 7
Self-citationArtificial tumor matrices and bioengineered tools for tumoroid generation
Liu, Y., Chen, P., Chang, R., Liu, X., Jhang, J.-W., Enkhbat, M., Chen, S., Wang, H., Deng, C., & Wang, P. (2024) · Biofabrication · doi:10.1088/1758-5090/ad2534 · Cited by 8
Melanoma Brain Metastases Patient-Derived Organoids: An In Vitro Platform for Drug Screening
Abedellatif, S.-E., Hosni, R., Waha, A., Gielen, G. H., Banat, M., Hamed, M., Güresir, E., Fröhlich, A., Sirokay, J. D., Wulf, A., et al. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16081042 · Cited by 9
Wang, Y., Sun, X. Y., Lu, B., Zhang, D., Yin, Y., Liu, S., Chen, L., & Zhang, Z. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177368 · Cited by 9
Endocrine cancer organoids in basic and translational medical research
Chen, D., Chen, Z., Yang, H., Zhang, L., Hu, C., Yang, Z., Li, P., Su, X., Liu, X., Wei, W., et al. (2025) · Science China Life Sciences · doi:10.1007/s11427-024-2888-8 · Cited by 6
Discovery and Validation of Circulating EVL mRNA as a Prognostic Biomarker in Pancreatic Cancer
Du, Y., Yao, K. T., Feng, Q., Mao, F., Xin, Z., Xu, P., & Yao, J. J. (2021) · Journal of Oncology · doi:10.1155/2021/6656337 · Cited by 7
Sankarasubramanian, S., Pfohl, U., Regenbrecht, C. R. A., Reinhard, C., & Wedeken, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.760705 · Cited by 7
Labori, K. J. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.839339 · Cited by 7
Single Cell RNA Sequencing: A New Frontier in Pancreatic Ductal Adenocarcinoma
Zerdan, M. B., Shatila, M., Sarwal, D., Bouferraa, Y., Zerdan, M. B., Allam, S., Ramovic-Zobic, M., & Graziano, S. L. (2022) · Cancers · doi:10.3390/cancers14194589 · Cited by 7
The application of pancreatic cancer organoids for novel drug discovery
Melzer, M. K., Resheq, Y. J., Navaee, F., & Kleger, A. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2194627 · Cited by 7
Usman, O. H., Kumar, S., Walker, R. R., Xie, G., Sumajit, H. C., Jalil, A. R., Ramakrishnan, S., Dooling, L. J., Wang, Y. J., & Irianto, J. (2023) · Molecular Biology of the Cell · doi:10.1091/mbc.e23-02-0075 · Cited by 7
Hawkins, H. J., Yacob, B. W., Brown, M. E., Goldstein, B. R., Arcaroli, J. J., Bagby, S. M., Hartman, S. J., MacBeth, M. L., Goodspeed, A. E., Danhorn, T., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0298808 · Cited by 7
Kelly, K. N., Macedo, F. I., & Merchant, N. B. (2020) · Advances in Surgery · doi:10.1016/j.yasu.2020.05.001 · Cited by 7
Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer
Merz, V., Mangiameli, D., Zecchetto, C., Quinzii, A., Pietrobono, S., Messina, C. G. M., Casalino, S., Gaule, M., Pesoni, C., Vitale, P., et al. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.866173 · Cited by 7
Nelson, S. R., & Walsh, N. (2020) · Cancers · doi:10.3390/cancers12051233 · Cited by 8
Minoli, M., Cantore, T., Kiener, M., Fedrizzi, T., Manna, F. L., Karkampouna, S., Genitisch, V., Rodríguez, A., Klima, I., Gasperini, P., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.31.486514 · Cited by 7
Trellis Single-Cell Screening Reveals Stromal Regulation of Patient-Derived Organoid Drug ResponsesPreprint
Zapatero, M. R., Tong, A., Sufi, J., Vlckova, P., Rodriguez, F. C., Nattress, C. B., Qin, X., Hochhauser, D., Krishnaswamy, S., & Tape, C. J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.19.512668 · Cited by 7
Dai, L.-J., Li, Y., Ma, D., Shao, Z., & Jiang, Y. (2023) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2023.0286 · Cited by 7
The Evolution of Mouse Models of Cancer: Past, Present, and FuturePreprint
Abate-Shen, C. T., & Politi, K. A. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041736 · Cited by 7
Drug screening at single-organoid resolution via bioprinting and interferometry
Tebon, P. J., Wang, B., Markowitz, A. L., Davarifar, A., Krawczuk, P., Murray, G., Nguyen, H. T. L., Tavanaie, N., Nguyen, T. L., Boutros, P. C., et al. (2021) · doi:10.1101/2021.10.03.462896 · Cited by 155
He, Y., Wang, Z., Li, J., Wang, X., Zhao, C.-Y., Huang, X., & Zheng, L. (2024) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v16.i11.4506 · Cited by 6
Liu, Z., Jia, B., Zhai, Z., Wu, F., Jia, B., Yang, Z., & Zhang, Y. (2025) · The FASEB Journal · doi:10.1096/fj.202500423r · Cited by 6
Engineering Complexity: Advances in 3D Breast Cancer Models for Precision Oncology
Jeong, W., & Lee, S. J. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202503104 · Cited by 8
Reconstituting the head and neck tumor microenvironment with air-liquid interface organoids
Zheng, L., Tang, W., Guo, S., Chen, L., Wang, S., Liu, F., & Meng, J. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2025.1736505 · Cited by 7
Mastering Organoid Growth: A Complete Guide to Overcoming Methodological Challenges
Jiao, C., Karakaya, O. F., Dadgar, N., Wehrle, C. J., Massoud, Z., Hong, H., Fairchild, R. L., Leipzig, N. D., Aucejo, F., Ma, W. W., et al. (2026) · MedComm · doi:10.1002/mco2.70571 · Cited by 9
c-Myc/GRPEL1 maintains fatty acid synthesis via FASN to support PDAC cell proliferation
Wang, J., Zhang, L., Chen, K., Wei, F. Z., Li, W., Cui, C., Chen, F., Wei, B., Huang, T., Fang, H., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08439-0 · Cited by 6
Wang, Y., Diao, P., Lv, P., Qi, N., Wang, Z., Yan, E., Li, J., Wang, Y., Wang, D., Wu, Y., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102622 · Cited by 6
Xia, M., Wu, G., Wu, D., Hu, W., Deng, H., & Wang, S. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.03.013 · Cited by 7
Organoids in cancer therapy: translational applications and clinical promise
Bai, M., Liu, M., Wang, S., Ran, M., Ye, J., 薛玉芹, Zhang, C., Wang, Y., Lu, J., Dai, F., et al. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02678-7 · Cited by 6
Liu, C., Leighow, S. M., McIlroy, K., Lu, M., Dennis, K. A., Abello, K., Brown, D. J., Moore, C. J., Shah, A., Inam, H., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101227 · Cited by 7
Ye, H., Zhou, D., Li, H., Lv, J., Huang, H.-Q., She, J.-J., Nie, J., Li, T., Lu, M., Du, B., et al. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02595-w · Cited by 6
Understanding the Conundrum of Pancreatic Cancer in the Omics Sciences Era
Nicoletti, A., Paratore, M., Vitale, F., Negri, M., Quero, G., Esposto, G., Mignini, I., Alfieri, S., Gasbarrini, A., Zocco, M. A., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147623 · Cited by 8
Metadata
- Authors
- Tiriac, H., Belleau, P., Engle, D. D., Plenker, D., Deschênes, A., Somerville, T. D. D., Froeling, F. E. M., Burkhart, R. A., Denroche, R. E., Jang, G.-H., Miyabayashi, K., Young, C. M., Patel, H., Ma, M., LaComb, J. F., Palmaira, R. L. D., Javed, A. A., Huynh, J. C., Johnson, M., Arora, K., Robine, N., Shah, M., Sanghvi, R., Goetz, A. B., Lowder, C. Y., Martello, L., Driehuis, E., LeComte, N., Askan, G., Iacobuzio-Donahue, C. A., Clevers, H., Wood, L. D., Hruban, R. H., Thompson, E., Aguirre, A. J., Wolpin, B. M., Sasson, A., Kim, J., Wu, M., Bucobo, J. C., Allen, P., Sejpal, D. V., Nealon, W., Sullivan, J. D., Winter, J. M., Gimotty, P. A., Grem, J. L., DiMaio, D. J., Buscaglia, J. M., Grandgenett, P. M., Brody, J. R., Hollingsworth, M. A., O'Kane, G. M., Notta, F., Kim, E., Crawford, J. M., Devoe, C., Ocean, A., Wolfgang, C. L., Yu, K. H., Li, E., Vakoc, C. R., Hubert, B., Fischer, S. E., Wilson, J. M., Moffitt, R., Knox, J., Krasnitz, A., Gallinger, S., & Tuveson, D. A.
- Affiliations
- Cold Spring Harbor Laboratory (US)
- Johns Hopkins University (US)
- Ontario Institute for Cancer Research (CA)
- Stony Brook University (US)
- Memorial Sloan Kettering Cancer Center (US)
- UC Davis Comprehensive Cancer Center (US)
- New York Genome Center (US)
- Thomas Jefferson University (US)
- SUNY Downstate Health Sciences University (US)
- Royal Netherlands Academy of Arts and Sciences (NL)
- 6Memorial Sloan Kettering Cancer Center, New York, New York.
- Broad Institute (US)
- Hofstra University (US)
- Donald & Barbara Zucker School of Medicine at Hofstra/Northwell (US)
- University of Pennsylvania (US)
- University of Nebraska Medical Center (US)
- Nebraska Medical Center (US)
- University Health Network (CA)
- Weill Cornell Medicine (US)
- 3PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
- Corresponding author
- Tuveson, David A.
- ORCID
- Tiriac, Hervé
- Engle, Dannielle D.
- Plenker, Dennis
- Deschênes, Astrid
- Somerville, Tim D. D.
- Froeling, Fieke E. M.
- Burkhart, Richard A.
- Denroche, Robert E.
- Jang, Gun-Ho
- Miyabayashi, Koji
- Young, C. Megan
- LaComb, Joseph F.
- Javed, Ammar A.
- Huynh, Jasmine C.
- Johnson, Molly
- Arora, Kanika
- Robine, Nicolas
- Sanghvi, Rashesh
- Lowder, Cinthya Y.
- Martello, Laura
- Driehuis, Else
- LeComte, Nicolas
- Clevers, Hans
- Wood, Laura D.
- Hruban, Ralph H.
- Aguirre, Andrew J.
- Wolpin, Brian M.
- Kim, Joseph
- Wu, Maoxin
- Bucobo, Juan Carlos
- Nealon, William
- Winter, Jordan M.
- Gimotty, Phyllis A.
- Grem, Jean L.
- DiMaio, Dominick J.
- Buscaglia, Jonathan M.
- Grandgenett, Paul M.
- Brody, Jonathan R.
- Hollingsworth, Michael A.
- O'Kane, Grainne M.
- Notta, Faiyaz
- Kim, Edward
- Crawford, James M.
- Devoe, Craig
- Ocean, Allyson
- Wolfgang, Christopher L.
- Yu, Kenneth H.
- Li, Ellen
- Vakoc, Christopher R.
- Fischer, Sandra E.
- Wilson, Julie M.
- Moffitt, Richard
- Knox, Jennifer
- Krasnitz, Alexander
- Tuveson, David A.
- Venue
- Cancer Discovery
- Published
- 2018-09-01
- Volume
- 8
- Issue
- 9
- Pages
- 1112-1129
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- PMC
- PMC6125219
- OpenAlex
- W2807088563
- Cited by
- 1,092
- References
- 62
- Citations by year
- 2026: 132 · 2025: 135 · 2024: 147 · 2023: 130 · 2022: 150 · 2021: 168 · 2020: 128 · 2019: 83 · 2018: 16
- FWCI
- 36.76
- Type
- journal article
- Language
- en
- Open access
- green
- pure.knaw.nl
- Licence
- other-oa
- Locations
- Cancer Discovery (publishedVersion)
- PubMed (publishedVersion)
- KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (publishedVersion, other-oa)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Funders
- HHS | National Institutes of Health (NIH) (5P30CA45508-29, 5P50CA101955-07, P20CA192996-03, 1U10CA180944-04, 5U01CA168409-5, 1R01CA188134-01, 1R01CA190092-04, HHSN26100008)
- Lustgarten Foundation
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- pancreatic cancer, patient-derived organoids, chemotherapy response, chemotherapy response prediction, predictive biomarkers, transcriptomic subtypes, cancer driver genes, gene expression signatures, synchronous metastases, chemotherapy-refractory disease, targeted therapy, precision medicine, adjuvant chemotherapy
- MeSH terms
- Antineoplastic Agents, Drug Screening Assays, Antitumor, Humans, Organoids, Pancreatic Neoplasms, Prospective Studies, Tumor Cells, Cultured, Gene Expression Regulation, Neoplastic, Sequence Analysis, RNA, Drug Resistance, Neoplasm, Gene Expression Profiling, Gene Regulatory Networks, Precision Medicine, Molecular Targeted Therapy, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
